Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J myeloma drug, in combo regimen, delays worsening of the disease
J&J myeloma drug, in combo regimen, delays worsening of the disease
J&J myeloma drug, in combo regimen, delays worsening of the disease
Submitted by
admin
on June 5, 2016 - 12:01pm
Source:
Yahoo/Reuters
News Tags:
JNJ
Multiple Myeloma
Darzalex
Takeda
Velcade
ASCO 2016
Headline:
J&J myeloma drug, in combo regimen, delays worsening of the disease
Do Not Allow Advertisers to Use My Personal information
